The Impact of COVID-19 on Diabetes Research
A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.
This episode of the Endocrine Outlook features a conversation with Jamie Hartmann-Boyce, MA, DPhil, a senior research fellow and departmental lecturer at the Nuffield Department of Primary Care Health Sciences of University of Oxford, focused on diabetes research during the COVID-19 pandemic.
Dr. Hartmann-Boyce is the lead investigator of an article published in Diabetes Care, titled “Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters,” providing an overview of potential associations between COVID-19 and diabetes. Published in May, the article proved to be a valuable resource for clinicians in recent months. That being said, much has changed in the current landscape since the article’s publication so we reached out to Dr. Hartmann-Boyce to learn more about the role of medical research during the COVID-19 era.
